Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Number of holders
-
831
-
Total 13F shares, excl. options
-
175,078,644
-
Shares change
-
+750,517
-
Total reported value, excl. options
-
$25,484,757,626
-
Value change
-
+$115,064,600
-
Put/Call ratio
-
77.54%
-
Number of buys
-
355
-
Number of sells
-
-364
-
Price
-
$145.57
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2018
919 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q2 2018.
Edwards Lifesciences Corp - Common Stock (EW) has 831 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 175,078,644 shares
of 590,231,680 outstanding shares and own 29.66% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (21,459,710 shares), BlackRock Inc. (15,484,861 shares), STATE STREET CORP (8,239,993 shares), Bank of New York Mellon Corp (7,465,289 shares), SANDS CAPITAL MANAGEMENT, LLC (6,917,432 shares), FMR LLC (6,714,684 shares), WELLINGTON MANAGEMENT GROUP LLP (6,341,293 shares), ALLIANCEBERNSTEIN L.P. (4,811,530 shares), BROWN ADVISORY INC (3,866,016 shares), and NORGES BANK (3,378,563 shares).
This table shows the top 831 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.